“Effectiveness and safety of first-generation protease inhibitors in real-world patients with hepatitis C virus genotype 1 infection in Brazil: a multicenter study” (2017) Clinics, 72(6), pp. 378–385. doi:10.6061/clinics/2017(06)08.